TNXP - Tonix Pharmaceuticals Holding Corp logo

TNXP

Tonix Pharmaceuticals Holding Corp

Rev โ€”top 1%10Y
Hold

Tonix Pharmaceuticals develops therapies for central nervous system disorders, immunology, and rare diseases. Its products include TONMYA for fibromyalgia and treatments for migraines, cocaine intoxication, kidney transplant rejection, and various other conditions.

โš•๏ธ Healthcare NASDAQ Listed 2012 $ USD
$1,000 invested 10 years ago โ†’$0today

Score Overview

1 Year
Score
Net Growth-18.84%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth33.94%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Scoreโ€”
Net Growth-59.83%
Net Trend20%
Net Income Consistencyโ€”
Rev Growthโ€”
Rev Trend80%
Revenue Consistencyโ€”
10 Years
Scoreโ€”
Net Growth-279.45%
Net Trend20%
Net Income Consistency
Rev Growthโ€”
Rev Trend50%
Revenue Consistency
All Time
Score
Net Growth-15594x
Net Trend21%
Net Income Consistency
Rev Growth9363x
Rev Trend36%
Revenue Consistency

See the full market ranking โ†’

Tonix Pharmaceuticals Holding Corp fundamental performance

Across Tonix Pharmaceuticals Holding Corp's full reported history, from 2012 to 2025, revenue grew from $ 1.88K to $ 13M and net income went from -$ 9.45K to -$ 124M. Revenue increased in 36% of the years measured; net income in 21%.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 11.97โ€”
1 Year2025-08-12
$ 59.76-79.97%
5 Years2021-08-12
$ 448K-100.00%
10 Years2016-08-12
$ 1000K-100.00%
All Time2012-05-10
$ 1000K-100.00%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 17M-$ 147M$ 185M
2025$ 13M-$ 124M$ 207M
2024$ 10M-$ 130M$ 98M
2023$ 7M-$ 116M$ 24M
2022$ 9M-$ 115M$ 120M
2021$ 0.00-$ 92M$ 178M
2020$ 2M-$ 50M$ 77M
2019$ 0.00-$ 28M$ 11M
2018$ 0.00-$ 26M$ 25M
2017$ 0.00-$ 21M$ 25M
2016$ 0.00-$ 38M$ 26M
2015$ 0.00-$ 48M$ 43M
2014$ 0.00-$ 27M$ 38M
2013$ 0.00-$ 10M$ 8M
IPO2012$ 1.88K-$ 9.45K$ 1M

Explore beyond TNXP

You're looking at Tonix Pharmaceuticals Holding Corp. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies